Profile picture

Professor Roxana Mehran

Icahn School of Medicine at Mount Sinai, New York City (United States of America)
Membership: FESC Member
Follow
Biography
Roxana Mehran, MD is an internationally renowned interventional cardiologist and clinical research expert in the field of cardiovascular disease. As Director of the Center for Interventional Cardiovascular Research and Clinical Trials at Mount Sinai, she has built a globally respected academic research center focused on developing randomized clinical trials, outcomes research projects and high impact academic publications. A prolific researcher, Dr. Mehran has served as principal investigator for numerous global studies, developed risk scores for bleeding and acute kidney injury, and participates regularly in developing national clinical guidelines. She has authored more than 1000 peer-reviewed articles and is one of the most highly cited researchers in the field of cardiology. Dr. Mehran has founded numerous nationally and internationally recognized initiatives and organizations which have served to push the field of cardiology forward, improving the care of patients around the world.
Logo ESC

Contributor content

Great Debate: TAVI should be the first procedure if a biological valve is chosen
Session
Great Debate: TAVI should be the first procedure if a biological valve is chosen
31 August 2025
Great Debate: following an acute coronary syndrome, the default duration of dual antiplatelet therapy should be 12 months
Session
Great Debate: following an acute coronary syndrome, the default duration of dual antiplatelet therapy should be 12 months
30 August 2025
Unravelling cardiovascular inflammation in atherosclerotic cardiovascular disease (ASCVD): from evidence to guidance
Session
Unravelling cardiovascular inflammation in atherosclerotic cardiovascular disease (ASCVD): from evidence to guidance
30 August 2025
Adjunctive antiplatelet therapy for patients undergoing percutaneous coronary intervention
Session
Adjunctive antiplatelet therapy for patients undergoing percutaneous coronary intervention
29 August 2025
Digital applications to guide precision cardiovascular interventions
Session
Digital applications to guide precision cardiovascular interventions
29 August 2025
HOT LINE 8
Session
HOT LINE 8
1 September 2024
Great Debate: mechanical circulatory support in cardiogenic shock - 'the course of true love never did run smooth'
Session
Great Debate: mechanical circulatory support in cardiogenic shock - 'the course of true love never did run smooth'
31 August 2024
Transforming TAVI practice: evidence, equity, and durability
Session
Transforming TAVI practice: evidence, equity, and durability
31 August 2024
ESC TV Perspectives - Cardiogenic shock & OHCA: the problems and the solutions
Session
ESC TV Perspectives - Cardiogenic shock & OHCA: the problems and the solutions
28 August 2023
Innovations in cardiovascular medicine that impact clinical practice
Session
Innovations in cardiovascular medicine that impact clinical practice
28 August 2023

ESC 365 is supported by